 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
With BlueGnome Buy, Illumina Expands Presence in Cyto Market, Moves into IVF Testing
September 25, 2012
With BlueGnome Buy, Illumina Expands Presence in Cyto Market, Moves into IVF Testing
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
January 29, 2013 / BioArray News - To Keep up with 'Rapid' Array Adoption, BlueGnome Moves into New HQ, Doubles Headcount
March 13, 2012 / BioArray News - BlueGnome Licenses Karyomapping IP in Bid to Bolster Pre-Implantation Genetic-Dx Play
October 19, 2010 / BioArray News - Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News